METABOLIC AGENTS IN THE TREATMENT OF ALCOHOLISM AND DIFFERENT CENTRAL NERVOUS SYSTEM DISEASES

Download full text PDF
Issue: 
3
Year: 
2016

Professor V. Kukes (1), MD; A. Zhestovskaya (1), Ya. Nartsissov (2), Candidate of Physicomathematical Sciences; E. Sheshegova (2), Candidate of Pharmaceutical Sciences; E. Tyukina (2) 1 -I.M. Sechenov First Moscow State Medical University 2 -Research Institute of Cytochemistry and Molecular Pharmacology, Moscow

The paper considers the possibilities of a threonine and pyridoxine combination used to treat different central nervous system diseases, as well as Biotredin® to relieve alcohol withdrawal syndrome with a predominance of psychopathological and somatic disorders for disactualization of pathological alcohol craving and for physical and mental stabilization in alcoholics in remission.
Keywords: 
psychiatry-narcology
central nervous system diseases
alcohol withdrawal syndrome
Biotredin®

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Afanas'ev V.V. Alkogol'nyj abstinentnyj sindrom. Monografija / 1. Intermedika, 2002.
  2. Moskvichev V.G. Diagnostika i lechenie alkogol'nogo abstinentnogo 2. sindroma // Lechaschij vrach. – 2004; 03/04: 70–3
  3. Ostrovskij Ju.M. i dr. Metabolicheskie predposylki i posledstvija 3. potreblenija alkogolja / Minsk: Nauka i tehnika, 1988; 233 s.
  4. http://biotredin.ru/4. Cooper J. Nutrition and the brain: what advice should we give? // Neurobiol. 5. Aging. – 2014; 35 (Suppl. 2): 79–83.
  5. Umarova H.Ja., Chugunov A.V., Kazakov A.Ju. Primenenie Biotredina v praktike nevrologa // Doktor.Ru. – 2014; 6–1 (94): 49–52.
  6. Takei N., Nawa H. mTOR signaling and its roles in normal and abnormal brain . development // Front. Mol. Neurosci. – 2014; 7: 28–33.
  7. Rehberg K., Kliche S., Madencioglu D. et al. The serine/threonine kinase . Ndr2 controls integrin trafficking and integrindependentneurite growth // J. Neurosci. – 2014; 34 (15): 5342–54.
  8. Hankey G., Ford A., Yi Q. et al. Effect of B vitamins and lowering homocysteine 9. on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis // Stroke. – 2013; 44 (8): 2232–9.
  9. Caram-Salas N., Reyes-Garcia G., Medina-Santill10. án R. et al. Thiamine and cyanocobalamin relieve neuropathic pain in rats: synergy with dexamethasone // Pharmacology. – 2006; 77 (2): 53–62.
  10. Kuwabara S., Nakazawa R., Azuma N. et al. Intravenous methylcobalamin 11. treatment for uremic and diabetic neuropathy in chronic hemodialysis patients // Intern. Med. – 1999; 38 (6): 472–5.
  11. Dolina S., Margalit D., Malitsky S. et al. Attention-deficit hyperactivity 12. disorder (ADHD) as a pyridoxine-dependent condition: urinary diagnostic biomarkers // Med. Hypotheses. – 2014; 82 (1): 111–6.
  12. Pangilinan P., Giacoletti-Argento A., Shellhaas R. et al. Neuropharmacology 13. in pediatric brain injury: a review // PMR. – 2010; 2 (12): 1127–40.
  13. Tazoe M., Ichikawa K., Hoshino T. Biosynthesis of vitamin B6 in Rhizobium: 14. in vitro synthesis of pyridoxine from 1-deoxy-D-xylulose and 4-hydroxy-L-threonine // Biosci. Biotechnol. Biochem. – 2002; 66 (4): 934–6.
  14. Gosudarstvennyj reestr lekarstvennyh sredstv. Biotredin. URL: 15. http://grls.rosminzdrav.ru (data obraschenija: 01.03.2014).
  15. Gusev E.I., Komissarova I.A., Alferova V.V. i dr. Opyt primenenija 16. metabolitnogo kompleksa preparatov Glitsin, Biotredin, Limontar v terapii ishemicheskogo insul'ta // Terra Medica. – 2001; 4: 37–8.
  16. Dzhumagaziev A.A., Belopasov V.V., Rahimova L.R. Primenenie metabo-17. litov u detej s perinatal'nymi gipoksicheski-ishemicheskimi porazhenijami TsNS. VII Rossijskij natsional'nyj kongress «Chelovek i lekarstvo» / M., 2000; s. 346.